A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)

Clinical trial NCT04775303 · UNKNOWN

Trial details

NCT number: NCT04775303
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Moderate to Severe Dry Eye

Start date: 2020-09-25
Primary completion: 2022-01-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.